Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Jain
Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated With Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Product Characteristics Associated With in Vivo Expansion of Anti-Cd19 Car T Cells in Patients Treated With Axicabtagene Ciloleucel (Axi-Cel)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Efficacy of Axicabtagene Ciloleucel (Axi-Cel) in Older Patients: Results From the Us Lymphoma Car-T Consortium
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prediction of Cadmium Pollutant With Ordinary Point Kriging Method Using Gstat-R
Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Neurological Toxicities and Coagulation Disorders in the Cytokine Release Syndrome During CAR-T Therapy
British Journal of Haematology
Hematology
Toxicities of CD19 CAR-T Cell Immunotherapy
American Journal of Hematology
Hematology